The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. You’re reading the web ...

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental ...

Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug ...

The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with ...

For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might ...

A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...

Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys than ...

Medicaid leaders and advocates say they’re shocked by the Trump administration’s harsh directives for implementing Medicaid ...

A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.

Oncologists are capable of some raucous applause, but they don’t bestow it upon just anyone. Today saw one of those coveted ...